Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	TG Therapeutics	Evotec	Schrödinger	Allakos	Turning Point Therapeutics
Symbol	NASDAQ:TGTX	OTCMKTS:EVTCY	NASDAQ:SDGR	NASDAQ:ALLK	NASDAQ:TPTX
Price Information
Current Price	$43.77	$78.10	$102.48	$121.18	$117.91
52 Week Range	Buy	Hold	Buy	Buy	Buy
MarketRank™
Overall Score	1.8	0.5	1.3	1.2	1.9
Analysis Score	3.5	0.0	1.4	1.3	4.5
Community Score	3.3	2.5	3.6	2.3	3.1
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	0.0	0.8	2.5	1.7
Earnings & Valuation Score	0.6	0.0	0.6	0.0	0.0
Analyst Ratings
Consensus Recommendation	Buy	Hold	Buy	Buy	Buy
Consensus Price Target	$64.00	N/A	$88.75	$133.00	$153.57
% Upside from Price Target	46.22% upside	N/A	-13.40% downside	9.75% upside	30.24% upside
Trade Information
Market Cap	$5.76 billion	$6.42 billion	$7.12 billion	$6.36 billion	$5.68 billion
Beta	2.28	1.13	N/A	1.02	1.23
Average Volume	1,541,776	1,130	802,272	317,362	260,944
Sales & Book Value
Annual Revenue	$150,000.00	$500.07 million	$85.54 million	N/A	N/A
Price / Sales	38,368.78	12.85	83.25	N/A	N/A
Cashflow	N/A	$1.43 per share	N/A	N/A	N/A
Price / Cash	N/A	54.59	N/A	N/A	N/A
Book Value	$0.39 per share	$7.08 per share	($15.25) per share	$10.19 per share	$11.28 per share
Price / Book	112.23	11.03	-6.72	N/A	N/A
Profitability
Net Income	$-172,870,000.00	$42.64 million	$-24,570,000.00	$-85,370,000.00	$-72,130,000.00
EPS	($1.83)	$0.56	N/A	($1.89)	($2.99)
Trailing P/E Ratio	N/A	433.91	0.00	N/A	N/A
Forward P/E Ratio	N/A	∞	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-151,798.69%	3.92%	-19.92%	N/A	N/A
Return on Equity (ROE)	-223.96%	3.96%	-7.25%	-29.18%	-23.81%
Return on Assets (ROA)	-108.08%	1.61%	-5.33%	-27.70%	-23.08%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.09%	0.90%	N/A	N/A	N/A
Current Ratio	3.35%	2.19%	15.81%	22.43%	35.45%
Quick Ratio	3.35%	2.13%	15.81%	22.43%	35.45%
Ownership Information
Institutional Ownership Percentage	65.73%	N/A	41.29%	65.35%	81.31%
Insider Ownership Percentage	13.20%	N/A	N/A	44.77%	23.20%
Miscellaneous
Employees	217	3,444	392	114	130
Shares Outstanding	131.49 million	82.26 million	69.49 million	52.50 million	48.17 million
Next Earnings Date	3/2/2021 (Confirmed)	3/25/2021 (Estimated)	3/4/2021 (Confirmed)	3/2/2021 (Estimated)	3/1/2021 (Confirmed)
Optionable	Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources